Protide HealthIn stock
ARA-290 (cibinetide) · 16 mg × 1 vial
$80.00$5.00 / mg
Checked · 5 days ago
Lab report: Not linked
View product details (opens in a new tab)No commercial relationship
Research listings · Peptides
ARA-290 (cibinetide) research listings: prices and suppliers
Research materials and consumer products belong to different categories. A listing, laboratory report, or research-use label does not establish suitability for personal use.
We have no commercial relationship with suppliers on this page. Offers are sorted by price per mg; commission never changes the order.
Prices observed weekly · last check · How we check prices →
Lowest current at 16 mg × 1 vial$5.00 / mg · $80.00Protide Health · checked 5 days ago
Listings at 16 mg × 1 vial
| Supplier link | |||||||
|---|---|---|---|---|---|---|---|
| Protide Health | 16 mg × 1 vial | $80.00 | $5.00 / mg | In stock | 5 d ago | Not linked | View product details (opens in a new tab)No commercial relationship |
| Biotech PeptidesProduct page includes use or preparation wording | 16 mg × 1 vial | $88.00 | $5.50 / mg | In stock | 5 d ago | Not linked | View product details (opens in a new tab)No commercial relationship |
| Core PeptidesProduct page includes use or preparation wording | 16 mg × 1 vial | $92.00 | $5.75 / mg | In stock | 5 d ago | Not linked | View product details (opens in a new tab)No commercial relationship |
- Biotech PeptidesProduct page includes use or preparation wordingIn stock
ARA-290 (cibinetide) · 16 mg × 1 vial
$88.00$5.50 / mg
Checked · 5 days ago
Lab report: Not linked
View product details (opens in a new tab)No commercial relationship - Core PeptidesProduct page includes use or preparation wordingIn stock
ARA-290 (cibinetide) · 16 mg × 1 vial
$92.00$5.75 / mg
Checked · 5 days ago
Lab report: Not linked
View product details (opens in a new tab)No commercial relationship
Out of stock · 1
The supplier showed these as out of stock when we last checked.
| Supplier link | |||||||
|---|---|---|---|---|---|---|---|
| Swiss ChemsProduct page includes use or preparation wording | 16 mg × 1 vial | $85.60 | $5.35 / mg | Out of stock | 5 d ago | Not linked | View product details (opens in a new tab)No commercial relationship |
- Swiss ChemsProduct page includes use or preparation wordingOut of stock
ARA-290 (cibinetide) · 16 mg × 1 vial
$85.60$5.35 / mg
Checked · 5 days ago
Lab report: Not linked
View product details (opens in a new tab)No commercial relationship
- Prices exclude shipping. A matching name does not verify the contents of a lot.
- Lab reports are vendor-reported, not independently authenticated. “Lab confirmed” means the issuing laboratory confirmed the report is theirs.
- Some suppliers’ product pages include use or preparation wording. We list their prices for comparison only; we do not endorse that wording, and nothing on this site is guidance on preparing or using these materials.
By size
Every package size we track for ARA-290 (cibinetide). Current means seen in the last 8 days.
| 10 mg × 1 vial | $39.15 | $3.92 / mg | 4 / 5 | 4 |
|---|---|---|---|---|
| 16 mg × 1 vial | $80.00 | $5.00 / mg | 3 / 4 | 3 |
| 50 mg × 1 vial | — | — | 0 / 1 | 0 |
| 10 mg × 1 bottle | $154.00 | — | 1 / 1 | 1 |
Research context
From our own records, with the date each was last checked.
- FDA approval
- No approved drug product with this ingredient listed in Drugs@FDA (data updated 2026-11-02)Checked
- 503A / 503B compounding
- 503A category 3 (nominated without adequate support), listed as cibinetide (ARA-290), on FDA's 2026-05-14 listChecked
- Advisory committee (PCAC)
- No PCAC discussion of cibinetide found in FDA's 2022 to 2027 committee meeting materials (checked 2026-11-03)Checked
- Rulemaking / enforcement
- No Federal Register document found for cibinetide (search on 2026-11-03)Checked
- Identity
- Formula C51H84N16O21 · MW 1257.3 g/mol · CAS 1208243-50-8Sequence pGlu-EQLERALNSS (N-terminal pyroglutamate)Source record Checked
Identity noteCibinetide is the official name; some listings spell it cibinitide.
How we check prices · Offers are matched to our catalogue by an editor before they appear; a listing is not an endorsement.